Certificate number:RU.77.99.88.003.Е.001351.03.17
Date of registration and renewal:21.03.2017
Dosage form: & nbspTablets weighing 280 mg.
Classification "Composition" & nbsp Other dietary supplements
Classification "Clinical" & nbsp BAD-source of monovitamins and vitamin-like substances
Composition: & nbspE460, E464, E171, E553b, polyethylene glycol, E468, E551, E470b, D-biotin.
Scope: & nbspDFor realization to the population as biologically active additive to food - an additional source of biotin.
Suggested Usage: & nbspAT1 tablet a day 1 times a day with meals, with water. Duration of admission is 1 month. After a break of 1 month, a second appointment is possible.
Contraindications:Individual intolerance of components, pregnancy, breast-feeding.
Special instructions:Before use, it is recommended to consult a doctor.
Shelf life:3 years.
Storage conditions: Store in a dry place inaccessible to children, at a temperature not exceeding + 25 ° С.
Research protocols:In exchange for the certificate of state registration No. RU.77.99.88.003.Е.008506.08.15 of 19.08.2015, the expert opinion of the FGBM of the Federal Targeted Register and the Federal Service for Consumer Protection of Russia No. 10-2FTS / 2966 of 03.08.2015.
Recipient:Kvayser Pharma, Open CompanyKvayser Pharma, Open Company Russian Federation
Information update date: & nbsp29.04.2017
Instructions
Up